NOVELLI, Mauro
 Distribuzione geografica
Continente #
NA - Nord America 4994
EU - Europa 4046
AS - Asia 1586
SA - Sud America 73
AF - Africa 36
OC - Oceania 36
Continente sconosciuto - Info sul continente non disponibili 18
Totale 10789
Nazione #
US - Stati Uniti d'America 4908
CN - Cina 983
IT - Italia 982
IE - Irlanda 541
FR - Francia 448
DE - Germania 331
FI - Finlandia 329
SE - Svezia 322
KR - Corea 288
UA - Ucraina 245
AT - Austria 218
PL - Polonia 188
GB - Regno Unito 159
JP - Giappone 85
VN - Vietnam 81
CA - Canada 74
DK - Danimarca 64
IN - India 55
ES - Italia 54
AU - Australia 32
BR - Brasile 32
BE - Belgio 31
TR - Turchia 27
SN - Senegal 25
NO - Norvegia 23
NL - Olanda 20
EU - Europa 18
GR - Grecia 16
RU - Federazione Russa 16
AR - Argentina 14
HU - Ungheria 11
PE - Perù 11
CL - Cile 10
HK - Hong Kong 10
CH - Svizzera 9
MX - Messico 9
RO - Romania 9
TW - Taiwan 9
CO - Colombia 6
HR - Croazia 6
ID - Indonesia 6
SG - Singapore 6
UZ - Uzbekistan 6
EG - Egitto 5
PT - Portogallo 5
AL - Albania 4
BY - Bielorussia 4
IL - Israele 4
MO - Macao, regione amministrativa speciale della Cina 4
NZ - Nuova Zelanda 4
PH - Filippine 4
TH - Thailandia 4
QA - Qatar 3
SK - Slovacchia (Repubblica Slovacca) 3
IR - Iran 2
SA - Arabia Saudita 2
SI - Slovenia 2
ZA - Sudafrica 2
AM - Armenia 1
BG - Bulgaria 1
BN - Brunei Darussalam 1
CR - Costa Rica 1
CZ - Repubblica Ceca 1
DZ - Algeria 1
EE - Estonia 1
GT - Guatemala 1
IQ - Iraq 1
JO - Giordania 1
LA - Repubblica Popolare Democratica del Laos 1
LV - Lettonia 1
MM - Myanmar 1
MT - Malta 1
MU - Mauritius 1
MY - Malesia 1
NG - Nigeria 1
PA - Panama 1
RS - Serbia 1
TN - Tunisia 1
Totale 10789
Città #
Chandler 838
Beijing 668
Dublin 540
Villeurbanne 289
Fairfield 253
Ann Arbor 244
Princeton 235
Jacksonville 229
Vienna 212
Medford 205
Torino 204
Houston 197
Wilmington 185
Dearborn 164
Warsaw 156
Woodbridge 146
Ashburn 140
Redwood City 135
Nyköping 108
Seattle 100
Cambridge 92
Pisa 81
Milan 79
Boston 61
Dong Ket 46
Boardman 44
Nanjing 41
Fremont 40
Shanghai 32
Toronto 30
Brussels 27
Guangzhou 26
Falls Church 25
Hefei 23
Jinan 23
Tokyo 23
Verona 20
Rome 19
San Diego 19
Norwalk 18
Kunming 14
Mountain View 13
Bologna 12
Chengdu 12
Florence 12
Hangzhou 12
Helsinki 12
Lachine 12
Silver Spring 12
Valdagno 12
Des Moines 11
New York 11
Philadelphia 11
Lima 10
Venezia 10
Chicago 9
Detroit 9
Paris 9
Pavia 9
Rochester 9
San Antonio 9
Seoul 9
Baotou 8
Istanbul 8
Nanchang 8
Napoli 8
Ottawa 8
Shenyang 8
São Paulo 8
Trondheim 8
Bergen 7
Changsha 7
Gurgaon 7
Hebei 7
Madrid 7
Montréal 7
Nichelino 7
Pontevedra 7
Saluzzo 7
San Francisco 7
Santiago 7
Taipei 7
Turin 7
Berlin 6
Davis 6
Hanoi 6
Montauro 6
Palermo 6
Phoenix 6
Redmond 6
Tampa 6
Xian 6
Athens 5
Barcelona 5
Bari 5
Bucharest 5
Budapest 5
Buffalo 5
Cleveland 5
Eau Claire 5
Totale 6505
Nome #
Th1, Th2, Th17 and Regulatory T Cell Pattern in Psoriatic Patients: Modulation of Cytokines and Gene Targets Induced by Etanercept Treatment and Correlation with Clinical Response. 497
Blood Flow Cytometry in Sézary Syndrome: New Insights on Prognostic Relevance and Immunophenotypic Changes During Follow-up. 405
Spiky follicular mycosis fungoides: a clinicopathologic study of 8 cases. 263
Regulatory T cells in skin lesions and blood of patients with bullous pemphigoid 237
Melanoma of the lower extremities: foot site is an independent risk factor for clinical outcome 218
Functional and Phenotypical Impairment of Polymorphonuclear Cells in Atopic Dermatitis: An Additional Cause for the Known Susceptibility to Infections? [*M.T. Fierro and G. Banche contributed equally to this work] 202
Phenotypical characterization of circulating cell subsets in pyoderma gangrenosum patients: the experience of the Italian immuno-pathology group 192
Circulating CD4+ CD25brightFOXP3+ regulatory T-cells are significantly reduced in bullous pemphigoid patients. 188
Regulatory T cells as well as IL-10 are reduced in the skin of patients with dermatitis herpetiformis 186
Functional and phenotypical alterations of polymorphonuclear cells in Sézary syndrome patients [*MT. Fierro and AMC Cuffini contributed equally to this work] 182
HPyV6, HPyV7 and TSPyV DNA sequences detection in skin disease patients and healthy subjects. 181
Human Endogenous Retrovirus Expression in Primary Cutaneous T-Cell Lymphomas 171
The inclusion complex of 4-hydroxynonenal with a polymeric derivative of Β-cyclodextrin enhances the antitumoralefficacyof the aldehyde in several tumor cell lines and in a three-dimensional human melanoma model 170
Alterazioni funzionali e fenotipiche dei polimorfonucleati nella sindrome di sezary 163
Expression of AP-2a, AP-2g and ESDN in primary melanomas: Correlation with histopathological features and potential prognostic value 160
Reciprocal modulation of circulating CD4+CD25+bright T cells induced by extracorporeal photochemotherapy in cutaneous T-cell lymphoma and chronic graft-versus-host-disease patients. 158
BRAF and MEK inhibitors increase PD1-positive melanoma cells leading to a potential lymphocyte-independent synergism with anti-PD1 antibody 151
Long-term evolution of an untreated primary cutaneous follicle center lymphoma of the scalp 135
Eruptive Dermal Clear Cell Desmoplastic Mesenchymal Tumors with Myofibroblastic Differentiation in a Young Boy. 129
Epstein-Barr virus in cutaneous T-cell lymphomas: evaluation of the viral presence and significance in skin and peripheral blood 124
Erythema multiforme-like lesions in primary cutaneous aggressive cytotoxic epidermotropic CD8+ T-cell lymphoma: A diagnostic and therapeutic challenge 114
miR-155 expression in Primary Cutaneous T-Cell Lymphomas (CTCL) 106
Studio citofluorimetrico della popolazione circolante CD4+CD27+ nelle eritrodermie infiammatorie e nei linfomi cutanei: relazione con i livelli di cellule CD4+CD26- ed utilità diagnostica. 103
Alterazioni funzionali e fenotipiche dei polimorfonucleati nei pazienti affetti da dermatite atopica 99
Alemtuzumab for the treatment of Sézary sindrome: clinical and immunological findings in 10 patients. 90
Linfoma cutaneo CD56 positivo: presentazione di un caso 88
Improved Anti-Tumoral Therapeutic Efficacy of 4-Hydroxynonenal Incorporated in Novel Lipid Nanocapsules in 2D and 3D Models 88
Malattia di Destombes-Rosai-Dorfman ad esclusivo interessamento cutaneo: studio istologico, immunoistochimico ed ultrastrutturale di un caso. 85
Micosi fungoide: dall'istopatologia alla biologia molecolare 82
[Serum levels of soluble receptors of interleukin-2 in skin pathology] 81
Human herpesvirus 7 detection by quantitative real time polymerase chain reaction in primary cutaneous T-cell lymphomas and healthy subjects: lack of a pathogenic role 81
Peripheral blood involvement in a mycosis fungoides patient with limited skin lesions: phenotypical features and homing molecule pattern 81
'Aleukemic' granulomatous leukemia cutis. 79
Endothelial and Smooth muscle cell Derived Neuropin-like molecule and AP-2 family protein expression in primary melanoma predicts Disease Free Survival in melanoma patients 79
Eritema polimorfo, Sindrome di Stevens-Johnson, Necrolisi epidermica tossica: istologia 78
Low-dose intermittent alemtuzumab in the treatment of Sézary syndrome: clinical and immunologic findings in 14 patients. 77
Adhesion molecules in lymphomatoid granulomatosis 76
Virus di Epstein-Barr e linfomi primitivi cutanei: valutazione della carica virale mediante PCR quantitativa-competitiva (QC-PCR) su biopsia. 76
Abstract 5603: Melanoma PD1 expression is upregulated by MAPK inhibitors leading to an immune-independent synergism with anti-PD1 antibodies 76
Evaluation of PMNs functional and phenotypical alterations in mycosis fungoides patients. 71
Collagenase digestion and mechanical disaggregation as a method to extract and immunophenotype tumour lymphocytes in cutaneous T-cell lymphomas. 71
Un caso di leucemia/linfoma a cellule T dell'adulto con localizzazioni cutanee: caratteristiche cliniche, istologiche ed immunologiche 70
Clinical and prognostic reports from 270 patients with multiple primary melanomas: a 34-year single-institution study 69
Low-dose intermittent Alemtuzumab in Sézary Syndrome: clinical activity, toxicity profile and immunological findings in 17 patients. 69
[Heterogenicity of T-cell cutaneous lymphomas: pleomorphic lymphoma of intermediate phenotype between the thymic and post-thymic stages. Study of 2 cases] 68
Clonal heterogeneity in mycosis fungoides/Sézary Syndrome: incidence, relation with clinico-pathologic features and prognostic significance 68
Linfociti Treg e fotoferesi 67
CD45RA+ immunophenotype in mycosis fungoides: clinical, histological and immunophenotypical features in 22 patients. 65
PCR Real time Mismatch Amplification Mutation Assay (MAMA Real Time PCR) for evaluation of TNFα promoter gene polymorphism -308 G/A in patients with psoriasis. 65
Variants of parvovirus B19: Bioinformatical evaluation of nested PCR assays and gentoypes detection 64
Le infezioni nella micosi fungoide e nella sindrome di Sézary 64
Adjuvant therapy of stage IIIb melanoma with interferon alfa-2b: clinical and immunological relevance 63
CD26 (DPP-IV)- A useful marker in Sezary sindrome 63
Prognostic factors in Sézary syndrome: a multivariate analysis of clinical, haematological and immunological features. 62
Multivariate analysis of prognostic factors in 58 Sézary syndrome patients 62
TCRgamma-Chain Gene Rearrangement by PCR-Based GeneScan: Diagnostic Accuracy Improvement and Clonal Heterogeneity Analysis in Multiple Cutaneous T-Cell Lymphoma Samples 61
TCRgamma-chain gene rearrangement by GeneScan: incidence and significance of clonal heterogeneity in Sézary syndrome. 61
CD26 expression on keratinocytes in normal skin, inflammatory skin diseases and cutaneous T-cell lymphomas (CTCL). 60
Bullous pemphigoid is characterised by a reduction of skin-homing/circulating FOXP3+ Tregs and by a down-regulation of the IL-10 pathway 60
Bullous, cutaneous, pleomorphic T-cell Lymphoma: analysis of integrins and extracellular matrix components. 60
[Role of immediate hypersensitivity in immune complex deposits: the platelet activating factor] 59
Phenotypical and functional alterations of polymorphonucleates in sezary syndrome patients 59
The relevance of the CD4+ CD26- subset in the identification of circulating Sézary cells. 59
Role of mastocyte dependent vasopermeabilization on immune complex deposition in lupus erythematosus glomerulonephritis. 58
CD26 expression on cutaneous infiltrates from patients CD26 expression on cutaneous infiltrates from patients with cutaneous T-cell lymphoma (CTCL) CD26 in cutaneous T-cell lymphoma patients. 57
FoxP3 expression on melanoma cells is related to early visceral spreading in melanoma patients treated by electrochemotherapy. 57
Prognostic factors in Sezary sindrome 57
Quantificazione mediante PCR dell’EBV-DNA da biopsie cutanee di pazienti con CTCL (micosi fungoide e sindrome di Sezary) 57
PAS expression is related to survival in Sézary syndrome patients 56
The immunological profile of melanoma and the role of adjuvant thymostimulin therapy in stage I patients. 56
Clinical presentation and immunological features of an Italian ATL case 56
Heterogeneity of Circulating CD4+ Memory T-Cell Subsets in Erythrodermic Patients: CD27 Analysis Can Help to Distinguish Cutaneous T-Cell Lymphomas from Inflammatory Erythroderma 54
Dytiscidae ed Helophoridae (Insecta, Coleoptera) del Parco Naturale del Mont Avic (Valle d'Aosta, Italia). 54
Functional and phenotypical alterations of polymorphonuclear cells in atopic dermatitis patients 54
Linfomi cutanei (non micosi fungoide) a cellule T CD30- 53
Circulating CD4+CD25 bright FOXP3+ T cells are up-regulated by biological therapies and correlate with the clinical response in psoriasis patients. 53
Atypical mononuclear cells in “Neutrophilic Dermatitis” 53
Prevalence and significance of human parvovirus variants in skin from primary cutaneous T cell lymphomas, inflammatory dermatoses and healthy subjects 53
T-cell receptor gamma gene rearrangement by multiplex polymerase chain reaction/heteroduplex analysis in patients with cutaneous T-cell lymphoma (mycosis fungoides/Sézary syndrome) and benign inflammatory disease: correlation with clinical, histological and immunophenotypical findings 52
CD26 expression on keratinocytes in normal skin, inflammatory skin diseases and cutaneous T-cell lymphomas (CTCL). 52
Disaggregazione meccanica e digestione enzimatica: metodo combinato ad elevata efficienza per l’estrazione dei linfociti infiltranti la cute. 52
Phenotypic features and TCR gene rearrangements patterns in Sezary sindrome: diagnostic, prognostic and response associated parameters 52
FOXP3 AND MELANOMA: THE BIG ESCAPE? 51
Therapy for metastatic melanoma: effective combination of dacarbazine, carmustine, cisplatin and tamoxifen. 51
Correlation between DNA-ploidy/cell cycle kynetics and histopathology in primary cutaneous B cell lymphomas 50
Flow cytometry immunophenotyping in mycosis fungoides 48
miR214 expression and interconnected endothelial and smooth muscle cell derived neutropilin-like molecule ESDN and AP-2 family protein expression in primary melanoma 48
Effects of topical calcipotriol on the expression of adhesion molecules in psoriasis. 47
Herpesviridae e parvoviridae DNA expression in CTCL: pathogenetic and prognostic role 47
Valutazione dei marcatori dell’apoptosi durante terapia con fotoferesi. 47
DNA from Human Polyomaviruses, MWPyV, HPyV6, HPyV7, HPyV9 and HPyV12 in Cutaneous T-cell Lymphomas 47
Development of a lux-real time PCR for human herpesvirus 7 (HHV7) in primary cutaneous T cell lymphomas 46
CD4+CD26- evaluation is a more useful diagnostic parameter than CD4+CD7- in Sézary syndrome (SS). 45
Ricerca di Parvovirus B19 e sue varianti (V9 e K71) in campioni di cute tramite nested PCR. 45
CD4+CD26- evaluation is a more useful diagnostic parameter than CD4+CD7- in Sézary syndrome (SS). 45
La sindrome di Sézary. 44
Entomofauna acquatica 44
Skin infiltrating lymphocyte flow-cytometric immunophenotyping: automated mechanical biopsy disaggregation and CD45 gating. 44
Treatment of Sézary Syndrome by anti-CD52 monoclonal antibodt Alemtuzumab: clinical and immunological findings in 24 patients 43
Phenotype instability in Sézary cells: follow-up results in 107 patients 43
Totale 9162
Categoria #
all - tutte 19036
article - articoli 0
book - libri 0
conference - conferenze 6522
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 25558


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2017/2018404 0000 00 00 02965751
2018/20191342 415813552 5590 92175 76138277153
2019/20201801 8268105195 124227 222171 206176111114
2020/20211202 202738065 10194 9558 12511176122
2021/20221433 40577488 10160 7969 5979306421
2022/20232266 33216452185 268608 246150 261000
Totale 11324